Applied Genetic Technologies (AGTC) to Offer Common Stock

Applied Genetic Technologies Corporation (Nasdaq: AGTC) announced that it has commenced an underwritten public offering of its common stock. All of the shares in the proposed offering are being sold by AGTC. In addition, AGTC expects to grant to the underwriter a 30-day option to purchase up to an additional 15% of shares of the common stock sold in the public offering. The offering is subject to market conditions and there can be no assurance as to whether or when the offering may be completed or as to the actual size or terms of the offering.

Cantor Fitzgerald & Co. is acting as the sole book-running manager for the offering.

You May Also Be Interested In

• KULR Technology extends ATM offering pause through September 2026
• Nuvation Bio prices $250M convertible notes offering due 2032
• Rubrik (RBRK) Reiterated at Overweight by Cantor Fitzgerald on Strong Q1 Beat